What are the sources of the stem cells used at Stem Cell Institute in Panama?

Lately, especially on our Facebook Page many people are asking us, “What is the source of the stem cells?”

Stem cells under fluorescent microscope.At the Stem Cell Institute, we use two types of stem cells. Primarily, we use allogeneic mesenchymal stem cells harvested from human umbilical cord tissue. In addition to allogeneic mesenchymal stem cells, our spinal cord injury protocol uses autologous (patient’s own) stem cells harvested from bone marrow.

Umbilical cord tissue is donated by mothers after normal, healthy births.

All donating mothers are tested for infectious diseases and have their medical histories screened. We obtain proper consent from each family prior to umbilical cord donation.

All mesenchymal stem cells harvested from umbilical cords are screened for infectious diseases to International Blood Bank Standards before they are approved for use in treatments.

A small number of umbilical cords (about 1 in 10) pass our rigorous screening process.

Dr. Riordan on the Umbilical Cord Selection Process at Stem Cell Institute

“Through retrospective analysis of our cases, we’ve identified proteins and genes that allow us to screen several hundred umbilical cord donations to find the ones that we know are most effective. We only use these cells and we call them ‘golden cells’.

We go through a very high throughput screening process to find cells that we know have the best anti-inflammatory activity, the best immune modulating capacity, and the best ability to stimulate regeneration.”

What are the advantages of treating with allogeneic human umbilical cord tissue (HUCT)-derived mesenchymal stem cells?

  • Anyone can be treated since HUCT mesenchymal stem cells are immune system privileged. Human Leukocyte Antigen (HLA) matching is not necessary.
  • The stem cells with the best anti-inflammatory activity, immune modulating capacity, and ability to stimulate regeneration can be screened and selected.
  • Allogeneic stem cells can be administered multiple times over the course of days in uniform dosages that contain high cell counts.
  • Umbilical cord tissue provides an abundant supply of mesenchymal stem cells.
  • No need to collect stem cells through invasive procedures such as liposuction or bone marrow collection
  • There is a growing body of evidence showing that mesenchymal stem cells from umbilical cords are more robust than mesenchymal stem cells from other sources such as fat.

The body’s immune system is unable to recognize human umbilical cord tissue (HUCT)-derived mesenchmyal stem cells as foreign and therefore they are not rejected. HUCT stem cells have been administered thousands of times at the Stem Cell Institute and there has never been a single instance rejection (graft vs. host disease). Umbilical cord-derived mesenchymal stem cells also proliferate/differentiate more efficiently than “older” cells, such as those found in the fat and therefore, they are considered to be more “potent”.

Watch Professor Arnold Caplan from Case Western Reserve University explain how this works.

Colton’s walking after stem cell therapy for cerebral palsy in Panama

Colton is planning on coming to Panama for follow-up treatment later this year. Here is a video of him walking from June 2015.

And here was Colton in 2014 about one year prior to the video above. This video was taken a year after his first treatments in 2013.

To keep up with Colton’s progress on Facebook, please visit: https://www.facebook.com/ColtonMittmanFundraiser

Stem cell treatment in Panama shows signs of hope for local Belle Fourche boy

By Karla J. Flack, Black Hills Pioneer

James Habeck and his mother Melissa

James Habeck and his mother Melissa

BELLE FOURCHE — Three-year old James Habeck and his family have returned from a medical trip to Panama. His mother Melissa Habeck said they are noticing signs of improvement as a result of the stem cell treatment James received at the Stem Cell Institute in Panama City, Panama.

Treatment is hoped to provide James with relief from some of the complications caused by his cerebral palsy and allow him to do things a toddler would normally be able to do such as talk, sit-up, walk, turn himself over in bed at night so he would have fewer sleeping issues, and use his hands and feet. Some with James’ condition have tight muscles, but James’ muscles are just limp.

Medical professionals told Melissa that the new stem cells would live actively in James for six months. During those six months of cell life, whatever James learns and the strength he gains should remain.

The Habecks returned to Belle Fourche June 7 and shortly thereafter James’ extensive line-up of therapy treatments began. He is on a fast track of learning and is currently undergoing speech, occupational, and physical therapies in both Rapid City and Belle Fourche.

This week he was fitted for a wheelchair and evaluated to see if an augmented and alternative communication device could help him communicate. If he can train his eyes to look at a particular item on the device his family will know what he is trying to communicate to them.

“They feel like he is stuck in his body, and that it is possible; he understands 75 percent of what I say to him,” Melissa said.
The Hebeck’s trip began May 31 and entailed an hour flight to Denver and six hours from Denver to Panama. James had never flown but he did well with the flights.

Melissa asked doctors why hospitals in the U.S. don’t offer the treatment James needs. The answer was FDA (Food and Drug Administration) regulations.

A Southlake, Texas, center recently opened. The extent of services offered is not being released at this time. [Note: This statement is not accurate. The Riordan-McKenna Institute in Southlake, Texas treats orthopedic conditions such as knee injuries and arthritis and rotator cuff injuries with a combination of bone marrow aspirate concentrate and AlphaGEMS amniotic membrane product. More information can be found at www.rmiclinic.com]

The Habecks met an athletic coach who was receiving stem cell treatment in Panama for multiple sclerosis. He said he was walking with a walker prior to his treatments. A filming crew was with him documenting his progress as he no longer has to use a walker after undergoing multiple stem cell treatments.

Melissa said staff at the Stem Cell Institute said a number of autistic patients come there for treatment. Heart failure, osteoarthritis, rheumatoid arthritis, spinal cord injury, and autoimmune diseases are also treated at the institute.
James had stem cells that were extracted from donated umbilical cords injected intravenously into his arms. The injections went fine some days but other days were problematic because his veins would rupture and the medical team would have to find a new vein. Melissa said by the end of the week both her and James were crying, but the staff was excellent in dealing with it.

“They were using a butterfly needle to access the veins but collapsing veins were still an issue and James was getting tired of getting poked with needles,” she said.

Melissa said she has been in contact with individuals who tried stem cell treatments that were not successful. She said people who had their own cells taken and then transferred back into their bodies told her their treatments were unsuccessful. She also said some who had gone to other countries and did the spinal stem cell procedures said those results weren’t positive. Melissa said she feels very positive about James’ treatment.

He has a special walker that he can use if someone pushes it for him.

“He took off by himself in his walker after treatment,” Melissa said.

He has also started trying to use his arms and legs to stabilize himself. He has more neck control and is trying to use his neck to raise his head. He has also shown improvement in efforts to gain eye contact with those who are talking to him. He has to fight for control as his eyes both stray separate ways.

Melissa said that when James was younger he tried to walk but then stopped trying; then he tried to sit. She was told that often times people with cerebral palsy have to abandon one thing to learn something else. Treatment will hopefully allow for a number of items to be learned and motor skills to be tackled simultaneously.

“He cried when they took the iPad from his sight on the plane and when the augmented and alternative communication device was taken from him,” Melissa said. This type of expression in connection with wanting something has not been something he was able to do in the past. She was happy he cried to have it back.

The Belle Fourche community rallied around the Habecks with a fundraiser March 22 wherein $20,000 was raised for James to have the stem cell treatment. Belle Fourche Police Chief Scott Jones and Belle Fourche Fire Chief Kip Marshall were taped to a building while raising funds and businesses donated door prizes. The Naja Shriners clowns helped raise funds Danielle Butler, James’ caregiver, organized the fundraiser. Many people joined together to help James. Melissa said she couldn’t believe it when it became possible for them to go for treatment.

Autistic Woodbridge boy making strides after stem cell treatment in Panama

By Suzanne Russell of myCentralJersey.com

Stem Cell Therapy Patient, Anthony Guerriero

Stem Cell Therapy Patient, Anthony Guerriero

WOODBRIDGE – John Guerriero has seen amazing improvements in his son, Anthony, since he underwent stem-cell treatment for his autism in December.

“It’s been life changing, and not just for Anthony,” said Guerriero.

He said his 7-year-old boy, a first-grade student at Matthew Jago School No. 28 in Woodbridge, is eating more foods, communicating more and in general is healthier and more comfortable in his skin.

“The best improvement is his connection with his brother and sister,” said Guerriero, who also has a son, Giovanni, 8, and daughter, Isabella, 5. “He didn’t have a relationship before with his brother. He was off in his own world. Now they are best friends. The three of them are inseparable.”

But with the stem-cell treatment lasting only about eight months before the body flushes it out of Anthony’s system, the family is preparing to return to Panama on June 29 for his next treatment.

Mayor’s Fluke Tournament

And helping them pay for the treatment, which is not covered by insurance, is the Mayor John E. McCormac Fluke Tournament on June 20 at the Sewaren Boat Launch. The event is organized by Woodbridge Police Officer Al Dudas, a 25-year veteran of the police department, and Police Capt. Robert Brady, assisted by Lt. Joseph Velez.

Dudas, a fisherman, said the mayor approached him nine years ago about holding a fishing tournament to raise money for kids with cancer and other medical conditions.

“When the money goes to a kid from town where we can see the improvement, it makes it that much more special,” said McCormac, who estimates that about $100,000 has been raised for families over the years.

Dudas said he goes to local stores and businesses to get donations for door prizes for the fishermen, as well as donations for the family. This year, the hall and catering also were donated.

Anthony Guerriero, two months after stem cell therapy in Panama

Anthony Guerriero, two months after stem cell therapy in Panama

At a captain’s meeting June 19 at the Avenel Knights of Columbus on Morrisey Avenue, a car dealer was scheduled to display trucks to haul boats and the New Jersey State Police was set to display a boat before a boatload of toys was presented to the three Guerriero children, along with about $15,000 for the family to use toward the $25,000 cost of travel, hotel and Anthony’s stem-cell treatment in Panama.

“When you see the faces of the kids and parents, it’s all worth it,” Dudas said.

And starting at 6 a.m. June 20, about 50 boats will participate in the fluke tournament, with $1,000 going to the fisherman who catches the largest fish. Last year, a fisherman reeled in a 13-pounder. Smaller prizes are awarded for the second-, third- and fourth-place finishers as well as the junior angler.

Sharon Aleszczyk, who, along with her husband, has volunteered to oversee the weighing of the fish, said the tournament is special to her.

“It’s close to my heart. They do so much for these families,” she said.

Guerriero said it’s great to have so much support from the community.

Autism diagnosis at age 2

Anthony was developing normally up until about 18 months old. Guerriero said his son used to talk, and walked before his first birthday. But at age 2, he was diagnosed with autism and retreated into his own world.

“He didn’t know who he was and who we were. He was mute for two years. It was difficult,” said Guerriero, who started researching autism and his son’s sudden loss of function.

His son underwent numerous tests and treatments before the family discovered stem-cell treatment. He said the treatment is so expensive that the family thought they would only be able to try it if they won the lottery.

The treatment is not approved in the U.S., although some clinical trials are underway, Guerriero said.

“But everyone chipped in money to send him there,” said Guerriero, adding that the change in his son was almost immediate.

He said his son’s skin was suddenly much softer, like he had found the fountain of youth.

“It was crazy. We were pretty encouraged,” said Guerriero, adding that the positive changes continued when they arrived back home, where his son was suddenly asking for different foods. He said Anthony had previously been so limited in the foods he would eat because of the pain he was in. He said his son now eats about 66 foods, mostly organic with no preservatives.

“He’s put on so much weight and filled out. He’s so healthy,” he said.

His behavior also has changed. Before the treatment, Guerriero said, his son suffered from major hyperactivity, climbing, bouncing, jumping, even walking on counter tops.

“He was not comfortable in his own skin,” said Guerriero, adding that the inflammation in his son’s brain and stomach played havoc on his body.

Since the treatment, Anthony hasn’t inappropriately climbed on things once.

“He’s done normal stuff as a boy. He’s super calm now,” said Guerriero, who hopes that with his son’s continued progress he will one day be able to verbalize the difference in how he felt before and after the treatment. “Now he’s talking to us and his siblings. He’s engaging with the whole family. It’s such an amazing journey. We see new things every single day.”

Guerriero said Anthony greets his mother, Jeannine, when she comes home, and he loves snuggling with her.

“They have that bond back,” he said.

Tax deductible donations for Anthony’s stem cell treatment can be directed to http://www.gofundme.com/unstoppableanthony.

If you are interested in following Anthony’s journey or would like to contact the Guerriero family with any questions about the procedure, go to https://www.facebook.com/UnstoppableAnthonyStemCellJourney.

2015-06-23T15:41:04+00:00June 23rd, 2015|Autism, Autism, News, Patient Stories, Stem Cell Therapy|

Duchenne’s Patient Ryan Benton Discusses His Experience with Stem Cell Therapy

Ryan Benton is the first patient in the United States to receive human umbilical cord-derived mesenchymal stem cell therapy for Duchenne’s muscular dystrophy. The US FDA granted Ryan this trial under compassionate use. Ryan first began treatments at the Stem Cell Institute in Panama before being able to receive treatments in his hometown of Wichita, Kansas.

2015-02-17T00:59:43+00:00February 17th, 2015|Duchenne's muscular dystrophy, News, Stem Cell Research|

Inside High School Football Report on Hall of Fame Coach and Stem Cell Recipient, Sam Harrell

Sam, who suffers from multiple sclerosis, was forced to retire as Ennis (Texas) High School’s head football coach due to his debilitating symptoms. Sam’s first two treatments using stem cells harvested from his own fat did not yield long lasting, positive results. However, after his third and fourth trips to the Stem Cell Institute in Panama for umbilical cord tissue-derived mesenchymal stem cells, Sam’s life turned around. Now, Sam is back in the game again!

Stem Cell Therapy for Multiple Sclerosis: Ron McGill

Ron McGill suffers from relapsing-remitting multiple sclerosis. He was started experiencing symptoms in 2009 but was not diagnosed with MS until January of 2013. He received several infusion and injections of human umbilical cord-tissue derived stem cells at the Stem Cell Institute in late October and Early November 2013.

In this video, Ron shares his story of discovery and recovery at a Stem Cell Institute seminar in San Antonio in October 2014.

For more information on MS therapy at the Stem Cell Institute in Panama, please visit: https://www.cellmedicine.com/stem-cell-therapy-for-multiple-sclerosis-3/

Good afternoon.

I was diagnosed with relapsing-remitting MS in January of 2013. My symptoms started with tingling and numbness in my hands and feet migraine headaches in April, 2009. Visits to the doctors concluded that job stress-related migraines were all it was.

My high tolerance for pain accepted the results and I went on with life. This was an extremely poor decision on my part. My symptoms remained constant but non-progressing until November of 2011. In attempting to kick a soccer ball, I lost my balance and I fell. I wrote it off as being out of shape and clumsy. A fall on a treadmill and down a stairwell in early 2012 was my final wakeup call. It solidified that there was more wrong with me than normal.

My quest to find out what was causing my issues and how to resolve them was started.

Starting from behind and (inaudible) to catch up, I did several things. I made immediate dietary changes. Sodas, fast food, canned food, alcohol – eliminated. Red meat, dairy, bread, pasta – reduced drastically. Chicken, fish, fresh fruits, vegetables – doubled. I went on a weight loss and body detox regimen. I replaced impact aerobic exercises I could no longer do with swimming.

I made the most of my insurance. I literally became a human pin cushion. Everybody was sticking me. I looked outside traditional medicine: acupuncturist, building my immune system and pure vitamin regimens. While I made great strides in changing my life, I was testing healthier, a progression of worse symptoms continued to happen. Severe leg and back aches, leg stingers, twitching, lost grip and more loss of balance.

It was determined that MS was my cause. My instability had me falling one to two times a month. I reached my lowest point waking up immobile from the waist down on a Wednesday morning in February of 2013.

With my motor skills seemingly erased from my memory, a deep cloud of panic overtook me. My confidence went out the window. I had to dig down extremely deep. I was able to regain mobility later that evening. I progressed to a penguin walk and very limited speed and distance over the next 6 months with the help of a walking stick and physical therapy.
Hours of online research for possible relief led to stem cell therapy.

After many months of research, doctor consultations, numerous conversations with people who had had stem cell therapy, heard about it, had relatives who had experienced it, I sent the email to the Stem Cell Institute.

After being accepted, I still had more conversations with Dr. Barnett and Cindy, asking more and more questions. They were extremely patient to everything I had.

The care provided for me upon my arrival and during my stay and departure in Panama was extremely good. The facility was simple, clean, efficient with a very helpful and friendly staff. The procedure was well-explained to me and carefully administered.

I was able to see results on my way back (on) November 3rd. I was able to walk farther and feel better. I was able to my walking stick in the back of my car for good two weeks later. Knock on wood, I haven’t fallen since October 23rd of 2013. My stamina, walking speed and stability have continued to increase. I do have momentary balance loss and heat can still wipe me out. My MS is still with me.

Do I feel (that) Panama was the right choice? For me, absolutely. I feel the infusion of healthy cells gave my body a huge boost to recover the majority of lost motor skills I had experienced. It also helped amplify the lifestyle changes I was already making to give me a faster and more positive result.

These successes have given me a more positive mental state that have allowed me to heal more and more.

What advice could I give you about stem cells? Research, research, research. There isn’t a price you can put on due diligence when it comes to your health. Make lifestyle changes at the cellular level in your body and amplify it with stem cell therapy.

In closing, I’d like to thank my wife for undying support and hours of research. I’d like to thank Dr. Riordan, (and) Stem Cell Institute for being at the cutting edge of healing diseases and I’d like to thank you all for allowing me to share with you today.

Neil Riordan, PhD Presents at American Academy of Anti-Aging Medicine’s 22nd Annual World Congress on Anti-Aging, Regenerative and Aesthetic Medicine in Orlando, May 15

Neil Riordan, PhD will Present “Umbilical Cord Mesenchymal Stem Cells in the Treatment of Autoimmune Diseases” at the 22nd Annual World Congress on Anti-Aging, Regenerative and Aesthetic Medicine at the Gaylord Palms Hotel in Orlando, Florida as part of the Specialty Workshop: “Stem Cells in Anti-Aging Medicine: An Update”.

Orlando, FL (PRWEB) May 13, 2014

Neil Riordan, PhD will Present “Umbilical Cord Mesenchymal Stem Cells (MSC) in the Treatment of Autoimmune Diseases” at the 22nd Annual World Congress on Anti-Aging, Regenerative and Aesthetic Medicine at the Gaylord Palms Hotel in Orlando, Florida as part of the Specialty Workshop: “Stem Cells in Anti-Aging Medicine: An Update”.

The primary focus of this workshop is to teach medical professionals how to successfully incorporate stem cell treatments into their practices. Expert faculty will cover stem cell theory and clinical trial research for all aspects of regenerative medicine as well as stem cell treatment marketing.

Dr. Riordan will discuss: Allogeneic mesenchymal stem cells’ mechanisms of immune modulating activities; the importance of MSC placement for clinical effect; human clinical trials demonstrating efficacy; alternative routes of MSC delivery; dose and frequency; and clinical safety of MSC.

The conference will be held from May 15 – 17, 2014 at the Gaylord Palms Hotel in Orlando, Florida. For more information, please visit http://www.a4m.com/anti-aging-conference-orlando-2014-may.html.

About Neil Riordan PhD
Dr. Riordan is the founder and chairman of Medistem Panama, Inc., (MPI) a leading stem cell laboratory and research facility located in the Technology Park at the prestigious City of Knowledge in Panama City, Panama. Founded in 2007, MPI stands at the forefront of applied research on adult stem cells for several chronic diseases. MPI’s stem cell laboratory is ISO 9001 certified and fully licensed by the Panamanian Ministry of Health. Dr. Riordan is the founder of Stem Cell Institute (SCI) in Panama City, Panama (est. 2007).

Under the umbrella of MPI subsidiary Translational Biosciences, MPI and SCI are currently conducting five IRB-approved clinical trials in Panama for multiple sclerosis, rheumatoid arthritis and osteoarthritis using human umbilical cord-derived mesenchymal stem cells, mesenchymal trophic factors and stromal vascular fraction. Additional trials for spinal cord injury, autism and cerebral palsy are slated to commence in 2014 upon IRB approval.

Dr. Riordan is an accomplished inventor listed on more than 25 patent families, including 11 issued patents. He is credited with a number of novel discoveries in the field of cancer research since the mid-1990s when he collaborated with his father Dr. Hugh Riordan on the effects of high-dose intravenous vitamin C on cancer cells and the tumor microenvironment. This pioneering study on vitamin C’s preferential toxicity to cancer cells notably led to a 1997 patent grant for the treatment of cancer with vitamin C. In 2010, Dr. Riordan received another patent for a new cellular cancer vaccine.

Dr. Riordan is also the founder of Aidan Products, which provides health care professionals with quality nutraceuticals including Stem-Kine, the only nutritional supplement that is clinically proven to increase the amount of circulating stem cells in the body for an extended period of time. Stem-Kine is currently sold in 35 countries.

Dr. Riordan earned his Bachelor of Science at Wichita State University and graduated magna cum laude. He received his Master’s degree at the University of Nebraska Medical Center. Dr. Riordan completed his education by earning a Ph.D. in Health Sciences at Medical University of the Americas.

About Stem Cell Institute Panama
Founded in 2007 on the principles of providing unbiased, scientifically sound treatment options; the Stem Cell Institute (SCI) has matured into the world’s leading adult stem cell therapy and research center. In close collaboration with universities and physicians world-wide, our comprehensive stem cell treatment protocols employ well-targeted combinations of autologous bone marrow stem cells, autologous adipose stem cells, and donor human umbilical cord stem cells to treat: multiple sclerosis, spinal cord injury, osteoarthritis, rheumatoid arthritis, heart disease, and autoimmune diseases.

In partnership with Translational Biosciences, a subsidiary of Medistem Panama, SCI provides clinical services for ongoing clinical trials that are assessing safety and signs of efficacy for osteoarthritis, rheumatoid arthritis, and multiple sclerosis using allogeneic umbilical cord tissue-derived mesenchymal stem cells (hUC-MSC), autologous stromal vascular fraction (SVF) and hU-MSC-derived mesenchymal trophic factors (MTF). In 2014, Translation Biosciences expects to expand its clinical trial portfolio to include spinal cord injury, heart disease, autism and cerebral palsy.

For more information on stem cell therapy:

Stem Cell Institute Website: http://www.cellmedicine.com

Stem Cell Institute
Via Israel & Calle 66
Plaza Pacific Office #2A
Panama City, Panama

About Medistem Panama Inc.

Since opening its doors in 2007, Medistem Panama Inc. has developed adult stem cell-based products from human umbilical cord tissue and blood, adipose (fat) tissue and bone marrow. Medistem operates an 8000 sq. ft. ISO 9001-certified laboratory in the prestigious City of Knowledge. The laboratory is fully licensed by the Panamanian Ministry of Health and features 3 class 10000 clean rooms, class 100 laminar flow hoods, and class 100 incubators.

Medistem Panama Inc.
Ciudad del Saber, Edif. 221 / Clayton
Panama, Rep. of Panama

Phone: +507 306-2601
Fax: +507 306-2601

Web site: http://www.medistempanama.com

About Translational Biosciences
A subsidiary of Medistem Panama Inc., Translational Biosciences was founded solely to conduct clinical trials using adult stem cells and adult stem cell-derived products.

Translational Biosciences Web Site: http://www.translationalbiosciences.com

Stem Cell Therapy for spinal cord injury: Theo Kostoulas

Theo Kostoulas is a T-6 complete spinal cord injury patient. He received a course of 16 stem cell therapy injections using umbilical cord-derived stem cells and his own bone marrow-derived stem cells. The cells were injected both intravenously and intrathecally (into the spinal fluid). During his stay in Panama and as part of his treatment protocol, Theo went to 19 physical therapy sessions over the course of month.

“I can definitely say that after the second injection, I immediately actually started getting some leg sensation and touch back from below my injury level. It was me lying in bed while my mother was putting my sock on my feet. I was actually able to feel that and it was pretty amazing because I haven’t had and feeling or sensation at all from my injury level of T-6. Now, more towards the end here, I have actually been able to have bladder sensation. I am a person that usually cath’ed myself every four hours but now because I do have this sensation coming back, I tend to wait until I have the need to have to go. So it can be anywhere from six to seven hours. If I need to drink a lot of water before coming to treatment, I know ahead of time whether I need to cath myself sooner or not.”

Patients beware: “Point of care” fat stem cell separation and counting kits inaccurate and not US FDA approved for humans.

An informative paper by Mary Pat Moyer, PhD detailing why “same-day” fat stem cell kits that are becoming more common in doctors’ offices across the US can miscount “stem cells” by large factors leading to over estimation of stem cell counts by as much as 20 times or more.

It also states, “no complete harvest and cell isolation systems have been approved by the FDA for autologous SVF harvest for immediate use [in humans].” These are just a couple of the arguments presented that demonstrate why it’s important to process adipose tissue properly in a professional lab setting.

Morrison DG, Hunt DA, Garza I, Johnson RA, Moyer MP*. Counting and Processing Methods Impact Accuracy of Adipose Stem Cell Doses. BioProcess J, 2012; 11(4): 4-17.

2013-01-22T23:15:25+00:00January 22nd, 2013|Adipose Stem Cells, Adult Stem Cells, News, Stem Cell Research|